CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Operating activities:
Net income (loss) from operations	$ 84,131	$ (2,647,500)
Consolidated net income from discontinued operations	(41,261)	(360,782)
Adjustments to reconcile consolidated net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	14,969	16,183
Amortization of notes discount	0	853,417
Interest expense related to make-whole amount	0	1,889,716
Income on Section 16 settlement	(400,000)	0
Changes in operating assets and liabilities:
Accounts receivable	1,424,935	(1,577,117)
Costs and estimated earnings in excess of billings on uncompleted contracts	$ (103,324)	(169,500)
Deferred contract costs		929
Current assets held for sale	$ (506,215)	1,188,498
Prepaid expenses and other current assets	84,464	(84,620)
Other assets	0	18,150
Other assets held for sale	(34,522)	179,591
Income taxes payable	(2,658)	(2,200)
Accounts payable and accrued expenses	(1,277,741)	2,082,017
Current liabilities held for sale	2,200,030	(559,652)
Accrued severance expense	0	(1,218,750)
Billings in excess of costs and estimated earnings on uncompleted contracts	125,355	(182,441)
Net cash provided by (used in) operating activities	1,650,685	(651,393)
Investing activities:
Acquisition of property and equipment	(10,707)	(137,314)
Net cash used in investing activities	(10,707)	(137,314)
Financing activities:
Borrowings under loan payable obligations	7,762	10,559
Repayments under other payable to Zurich	(135,000)	0
Repayments of short term convertible note	(4,000)	0
Dividend paid on preferred stock	0	(72,034)
Net cash provided by (used in) financing activities	1,443,762	(61,475)
Effect of exchange rate changes on cash	91,510	(7,939)
Net increase (decrease) in cash and cash equivalents	3,175,250	(858,121)
Cash and cash equivalents, beginning of the quarter	2,364,360	2,177,070
Cash and cash equivalents, end of the quarter	5,539,610	1,318,949
Schedule of non-cash investing and financing activities:
Declaration on preferred dividend payable	3,587,121	0
Warrants issued with convertible preferred stock	841,405	0
Deemed dividend on conversion of preferred stock to common stock	703,770	0
Conversion of dividends payable related to make-whole amount to common stock	3,375,792	0
Conversion of Series H preferred stock to common stock	691,768	0
Settlement of severance obligation and sale of Pride	0	970,000
Declaration on preferred dividends payable	0	74,487
Series F-1 Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of dividends payable related to make-whole amount to common stock	501,826	0
Convertible Series H-1 [Member]
Financing activities:
Proceeds from issuance of Series H-1 preferred stock and warrants	1,575,000	0
Series G-1 Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of dividends payable related to make-whole amount to common stock	158,481	0
Series F And F1 Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of Stock, Amount Converted	2,731,984	0
Series G And G1 Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of Stock, Amount Converted	1,084,230	0
Series H Preferred Stock [Member]
Schedule of non-cash investing and financing activities:
Conversion of Stock, Amount Converted	1,299,000	0
Pride [Member]
Adjustments to reconcile consolidated net loss to net cash provided by (used in) operating activities:
Gain on sale	$ 0	$ (798,896)